Haleon (HLN LN)

Analysis

Health Care • United Kingdom

Haleon is a British multinational consumer healthcare company specializing in everyday health products. The company offers a broad portfolio including oral health products (e.g., Sensodyne, parodontax), pain relief (e.g., Panadol, Advil), vitamins, minerals, and supplements (e.g., Centrum), and respiratory and digestive health solutions. Haleon is headquartered in Weybridge, England, and was established as an independent company on July 18, 2022.

Refresh

Exchange Announcement • 01 Oct 2026 15:00

Total Voting Rights and Capital

Exchange Announcement • 24 Sep 2026 17:45

Director/PDMR Shareholding

Exchange Announcement • 18 Sep 2026 18:00

Director/PDMR Shareholding

Exchange Announcement • 01 Sep 2026 15:00

Total Voting Rights and Capital

Exchange Announcement • 19 Aug 2026 16:05

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Total Voting Rights and Capital

Director/PDMR Shareholding

Director/PDMR Shareholding

Total Voting Rights and Capital

Cash Tender Offer - Pricing, Expiration and Result